These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15101187)

  • 21. Single photon emission computed tomography in Alzheimer's disease and related disorders.
    Newberg AB; Alavi A; Payer F
    Neuroimaging Clin N Am; 1995 Feb; 5(1):103-23. PubMed ID: 7743079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use and applications of single-photon emission computerised tomography in dementia.
    Geaney DP; Abou-Saleh MT
    Br J Psychiatry Suppl; 1990; (9):66-75. PubMed ID: 2291821
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
    Inui Y; Toyama H; Manabe Y; Sato T; Sarai M; Kosaka K; Iwata N; Katada K
    J Nucl Med; 2007 Oct; 48(10):1641-50. PubMed ID: 17873141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
    Jagust WJ; Reed BR; Seab JP; Kramer JH; Budinger TF
    Am J Physiol Imaging; 1989; 4(3):89-96. PubMed ID: 2789844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis of Alzheimer's disease using brain SPECT with three-dimensional stereotactic surface projections].
    Hanyu H; Asano T; Kogure D; Abe S; Iwamoto T; Takasaki M
    Rinsho Shinkeigaku; 2001 Sep; 41(9):582-7. PubMed ID: 11968741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [3-dimensional imaging of regional cerebral blood flow by means of emission computed tomography].
    Higano S; Uemura K; Kanno I
    Nihon Rinsho; 1990 Jul; 48(7):1591-8. PubMed ID: 2119464
    [No Abstract]   [Full Text] [Related]  

  • 27. Which attenuation coefficient to use in combined attenuation and scatter corrections for quantitative brain SPET?
    Zaidi H; Montandon ML
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):967-9; author reply 969-70. PubMed ID: 12212549
    [No Abstract]   [Full Text] [Related]  

  • 28. Cross-sectional and longitudinal studies of three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease.
    Osaki Y; Morita Y; Fukumoto M; Akagi N; Yoshida S; Doi Y
    Mov Disord; 2009 Jul; 24(10):1475-80. PubMed ID: 19441130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT.
    Imabayashi E; Matsuda H; Asada T; Ohnishi T; Sakamoto S; Nakano S; Inoue T
    J Nucl Med; 2004 Sep; 45(9):1450-7. PubMed ID: 15347711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral blood flow tomography by SPECT (single photon emission computerized tomography): Xenon-133 compared to isopropyl-amphetamine-iodine-123.
    Lassen NA; Henriksen L; Holm S; Barry DI; Paulson OB; Vorstrup S; Rapin JR; Le Poncin-Lafitte M; Moretti JL; Askienazy S; Raynaud C
    Ann Radiol (Paris); 1983 Jan; 26(1):53-8. PubMed ID: 6603190
    [No Abstract]   [Full Text] [Related]  

  • 31. Three-dimensional stereotactic surface projection study of freezing of gait and brain perfusion image in Parkinson's disease.
    Matsui H; Udaka F; Miyoshi T; Hara N; Tamaura A; Oda M; Kubori T; Nishinaka K; Kameyama M
    Mov Disord; 2005 Oct; 20(10):1272-7. PubMed ID: 16007622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of dementia using perfusion SPECT imaging at the patient's initial visit to a cognitive disorder clinic.
    Uchida Y; Minoshima S; Okada S; Kawata T; Ito H
    Clin Nucl Med; 2006 Dec; 31(12):764-73. PubMed ID: 17117070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.
    Silverman DH
    J Nucl Med; 2004 Apr; 45(4):594-607. PubMed ID: 15073255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative measurement of regional cerebral blood flow using N-isopropyl-(iodine-123)p-iodoamphetamine and single-photon emission computed tomography.
    Takeshita G; Maeda H; Nakane K; Toyama H; Sakakibara E; Komai S; Takeuchi A; Koga S; Ono M; Nakagawa T
    J Nucl Med; 1992 Oct; 33(10):1741-9. PubMed ID: 1403139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Brain perfusion imaging in amyotrophic lateral sclerosis with dementia].
    Ishikawa T; Morita M; Nakano I
    Brain Nerve; 2007 Oct; 59(10):1093-8. PubMed ID: 17969349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constant blood flow reduction in premotor frontal lobe regions in ALS with dementia - a SPECT study with 3D-SSP.
    Ishikawa T; Morita M; Nakano I
    Acta Neurol Scand; 2007 Nov; 116(5):340-4. PubMed ID: 17922728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET and SPECT in common neuropsychiatric disease.
    Tatsch K; Ell PJ
    Clin Med (Lond); 2006; 6(3):259-62. PubMed ID: 16826858
    [No Abstract]   [Full Text] [Related]  

  • 38. rCBF in neurodegenerative diseases as estimated by the autoradiographic (ARG) method and delayed I-123-IMP studies.
    Flores LG; Jinnouchi S; Nagamachi S; Nakahara H; Nishii R; Futami S; Tamura S
    Ann Nucl Med; 1999 Oct; 13(5):281-5. PubMed ID: 10582795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of functional imaging in Parkinsonism and dementia.
    Burn DJ; O'Brien JT
    Mov Disord; 2003 Sep; 18 Suppl 6():S88-95. PubMed ID: 14502661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single photon emission computed tomography in motor neuron disease with dementia.
    Sawada H; Udaka F; Kishi Y; Seriu N; Mezaki T; Kameyama M; Honda M; Tomonobu M
    Neuroradiology; 1988; 30(6):577-8. PubMed ID: 3265766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.